Ditchcarbon
  • Contact
  1. Organizations
  2. Quanterix Corporation
Public Profile
Medical Device Manufacturing
US
updated 2 months ago

Quanterix Corporation Sustainability Profile

Company website

Quanterix Corporation, a pioneering force in the life sciences sector, is headquartered in the United States. Founded in 2007, the company has established itself as a leader in the development of ultra-sensitive biomarker detection technologies, primarily serving the fields of neurology, oncology, and infectious diseases. Quanterix's flagship product, the Simoa® (Single Molecule Array) platform, offers unparalleled sensitivity and precision in measuring biomarkers, setting a new standard in diagnostics and research. This innovative technology enables researchers and clinicians to detect low-abundance proteins, facilitating breakthroughs in disease understanding and treatment. With a strong market position, Quanterix has achieved significant milestones, including partnerships with leading pharmaceutical companies and academic institutions. Their commitment to advancing precision medicine continues to drive their growth and influence in the industry.

DitchCarbon Score

How does Quanterix Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Quanterix Corporation's score of 25 is lower than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.

39%

Let us know if this data was useful to you

Quanterix Corporation's reported carbon emissions

Quanterix Corporation, headquartered in the US, currently does not have any publicly available carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, Quanterix Corporation's climate commitments and initiatives remain unclear. The company does not appear to inherit emissions data from any parent or related organizations, nor does it have any cascading targets from initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). In the context of the industry, it is essential for companies like Quanterix to establish clear climate commitments and reduction strategies to align with global sustainability goals. Without specific emissions data or targets, the company's environmental impact and commitment to climate action cannot be assessed.

How Carbon Intensive is Quanterix Corporation's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Quanterix Corporation's primary industry is Medical Device Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Quanterix Corporation's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Quanterix Corporation is in US, which has a low grid carbon intensity relative to other regions.

Quanterix Corporation's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Quanterix Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Quanterix Corporation's Emissions with Industry Peers

Labcorp Drug Development Inc.

US
•
Research and development services (73)
Updated 2 months ago

HTG Molecular Diagnostics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 18 days ago

Merck Millipore Limited

IE
•
Medical, precision and optical instruments, watches and clocks (33)
Updated about 1 month ago

Nanostring Technologies

US
•
Pharmaceutical Preparation Manufacturing
Updated 18 days ago

10x Genomics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 18 days ago

cytena GmbH

DE
•
Medical, precision and optical instruments, watches and clocks (33)
Updated about 1 month ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251120.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy